Add Yahoo as a preferred source to see more of our stories on Google. The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now ...
Teens are vulnerable to meningococcal meningitis, an unpredictable disease that can strike without warning and lead to ...
Thirty-four cases involved children ages 1 to 10; 41 patients not vaccinated against measles. Risk of meningococcal disease up in patients with anatomic/functional asplenia. The quadrivalent ...
From 2023 to 2024, coverage with one or more doses of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) and the quadrivalent meningococcal conjugate vaccine ...
(HealthDay)—For adolescents, the effectiveness of the one-dose meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine (MenACWY-D) decreases at three to less than ...
As your child enters the preteen years, you know you're in store for a whole lot of changes. Between growth spurts, new schools, and the push for independence, shots may be the last thing on your mind ...
Meningitis is a serious illness that causes inflammation of the membranes around the spinal cord and neck. It can be fatal without prompt treatment. The meningitis vaccine is one of the best ways to ...
The concomitant administration of multiple vaccines at a single clinic visit reduces the number of required visits to healthcare providers and can improve compliance with vaccine recommendations and ...
Colorado state law requires proof of two (2) valid Measles, Mumps and Rubella (MMR) vaccines OR proof of immunity (titers) for all incoming students. Colorado state law requires proof of one (1) valid ...
A college student has died and two people are being treated after cases of meningitis in Reading, Berkshire, the UK Health Security Agency (UKHSA) has said. It is entirely separate to the outbreak of ...
Hosted on MSN
Sanofi (SNY)’s MenQuadfi Becomes First MenACWY Vaccine Approved for Ages 6 Weeks and Up
The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now allowing its use in children as young as 6 weeks old. Previously approved ...
For the third consecutive year, HPV vaccination coverage remained stable, with 78.2 and 62.9% of adolescents having received 1 or more doses and being up to date with the HPV vaccination series, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results